Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.60% | 7.18% | 7.43% | 6.38% | 4.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.60% | 7.18% | 7.43% | 6.38% | 4.29% |
| Cost of Revenue | 4.19% | 6.46% | 8.33% | 7.71% | 7.21% |
| Gross Profit | 10.35% | 8.29% | 6.10% | 4.41% | 0.06% |
| SG&A Expenses | 5.30% | 1.29% | 1.80% | 1.01% | 1.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.31% | 6.00% | 7.43% | 6.98% | 6.88% |
| Operating Income | 14.69% | 14.57% | 7.45% | 2.93% | -9.41% |
| Income Before Tax | -6.01% | -3.10% | -5.68% | -6.03% | -12.66% |
| Income Tax Expenses | 31.74% | 18.41% | -6.90% | -0.75% | -6.00% |
| Earnings from Continuing Operations | -16.94% | -9.61% | -5.30% | -7.55% | -14.41% |
| Earnings from Discontinued Operations | -122.22% | -83.33% | -72.73% | 33.33% | 5.88% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.80% | -18.18% | 0.00% | -1.03% | -10.87% |
| Net Income | -18.12% | -10.70% | -6.20% | -7.48% | -14.78% |
| EBIT | 14.69% | 14.57% | 7.45% | 2.93% | -9.41% |
| EBITDA | 11.03% | 11.39% | 6.13% | 2.51% | -7.46% |
| EPS Basic | -27.83% | 12.70% | 88.41% | 340.79% | -- |
| Normalized Basic EPS | -6.09% | 37.71% | 109.85% | 377.45% | -- |
| EPS Diluted | -28.17% | 12.49% | 88.00% | 340.25% | -- |
| Normalized Diluted EPS | -6.70% | 37.07% | 109.23% | 376.78% | -- |
| Average Basic Shares Outstanding | 0.22% | 33.55% | 100.22% | 300.22% | -- |
| Average Diluted Shares Outstanding | 0.88% | 34.21% | 100.88% | 300.88% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |